The relevance of our findings is further supported by a research study demonstrating that CHK1 inhibitors in combination with chemotherapy dramatically reduced CSC survival in vitro by inducing premature cell cycle progression and mitotic catastrophe in non-small cell lung cancer 46. The gene discussed is CHEK1; the disease is non-small cell lung carcinoma.